How a global biopharma became a leader in ethical AI
EY teams used the global responsible AI framework to help a biopharma optimize AI governance, mitigate AI risks and protect stakeholders.
A detailed independent review of AI governance
EY teams collaborated with the biopharma to review its approach to AI ethics using the global responsible AI framework.
Driving responsible AI to reduce risk to stakeholders
EY teams helped the biopharma safeguard stakeholders, including the public, from AI ethical issues.
Featured press releases
JungJin SEO from South Korea named EY World Entrepreneur Of The Year 2021
LONDON, 10 JUNE 2021. JungJin SEO, Honorary Chairman of South Korea-based Celltrion Group, was this evening named EY World Entrepreneur Of The Year™ 2021 during a virtual awards ceremony broadcast live around the world.
10 Jun 2021 London GB
EY announces ambition to be carbon negative in 2021
LONDON, 25 JANUARY 2021. EY today announces an ambition to be carbon negative in 2021 by setting targets to significantly reduce its absolute emissions and removing and offsetting more carbon than it emits.
25 Jan 2021 London GB
More press releases
Technological advancements need to be harnessed to reach net zero targets in a post-COVID-19 world
LONDON, 24 NOVEMBER 2020. Technological advancements, such as hydrogen and artificial intelligence (AI), will have a critical role to play in reaching net zero in a post-COVID-19 world, according to the 56th EY Renewable Energy Country Attractiveness Index (RECAI).
24 Nov 2020
Next